Physician

David James Rawlinson, D.O.

According to 2025 Medicare claims, David Rawlinson, D.O. (NPI: 1699086140) practices ophthalmology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is SHORELINE OPHTHALMOLOGY, PLLC (NPI: 1679643670; TIN: 38-3245641) and primary practice location at 49444-1837. Rawlinson is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Rawlinson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 741 traditional Medicare patients, billed 1,980 HCPCS/CPT codes, and received $231,413 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 4,385 prescription claims across 949 beneficiaries totaling $250,322 in drug costs, led by Restasis (Cyclosporine). 2021 DME data shows 13 claims. Open Payments data shows 13 records totaling $301. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $156,874 to $231,413. Similarly, Part D prescription costs have moved sharply higher in recent years, from $30,596 to $250,322. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	795	1,660	$156,874
2016	495	966	$80,196
2017	531	1,276	$122,780
2018	584	1,453	$172,480
2019	803	1,954	$224,077
2020	731	1,840	$189,984
2021	771	1,972	$208,945
2022	703	1,812	$191,331
2023	780	1,850	$201,615
2024	741	1,980	$231,413

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	128	344	$30,596
2016	164	425	$28,407
2017	310	936	$34,782
2018	362	1,234	$55,029
2019	609	1,958	$98,652
2020	773	3,461	$147,615
2021	806	3,504	$183,946
2022	804	3,582	$208,903
2023	914	3,888	$241,196
2024	949	4,385	$250,322

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	12	12	$663
2018	24	24	$1,204
2019	38	38	$2,270
2020	28	28	$2,050
2021	13	13	$704
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
66984	Removal of cataract with insertion of prosthetic lens	179	308	$358
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	160	160	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	429	497	$78
92083	Exam of visual field with extended testing	125	126	$42
92136	Measurement of corneal curvature and depth of eye	231	346	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	46	2,640	$46,963
Restasis Multidose	Cyclosporine	52	1,572	$33,429
Latanoprost	Latanoprost	1,492	82,439	$22,347
Prednisolone Acetate	Prednisolone Acetate	441	18,870	$20,867
Lumigan	Bimatoprost	34	2,190	$14,695

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$301	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David James Rawlinson, D.O.?

Tedicare shows public-source Medicare data for David James Rawlinson, D.O. (NPI 1699086140), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David James Rawlinson, D.O. have ACO affiliation data?

David James Rawlinson, D.O. is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to David James Rawlinson, D.O.?

David James Rawlinson, D.O. is linked to SHORELINE OPHTHALMOLOGY, PLLC (billing NPI 1679643670) in the available physician profile data.

Does David James Rawlinson, D.O. have Open Payments data?

David James Rawlinson, D.O. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.